Drug makers lose choline alfoscerate suit against Government

Korea Biomedical Review

15 February 2022 - A court dismissed local drug makers’ appeal to nullify the Government’s push to negotiate the recollection of health insurance coverage for choline alfoscerate.

The Ministry of Health and Welfare said the Seoul Administrative Court ruled in favour of the ministry on Friday.

Read Korea Biomedical Review article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Market access , Korea